Literature DB >> 8346003

Carriage of Haemophilus influenzae type b in children after widespread vaccination with conjugate Haemophilus influenzae type b vaccines.

J C Mohle-Boetani1, G Ajello, E Breneman, K A Deaver, C Harvey, B D Plikaytis, M M Farley, D S Stephens, J D Wenger.   

Abstract

Rates of invasive Haemophilus influenzae type b (Hib) disease in children decreased very rapidly after licensure of Hib conjugate vaccines. A role for a vaccine-related reduction in nasopharyngeal carriage of Hib has been suggested. We studied oropharyngeal carriage of Hib and vaccination rates in a population of 2- to 5-year-old children in metropolitan Atlanta. Among 584 children 75% were vaccinated with an Hib conjugate vaccine, 17% had not been vaccinated and 8% had no vaccination records available. Forty-one percent of the children were colonized with H. influenzae. One child was colonized with Hib. Hib carriage (0.17%; upper 95% confidence interval boundary, 0.97%) was substantially lower than the estimates of Hib carriage from prior studies of children who had not received Hib conjugate vaccines. Our data are consistent with a decline in Hib carriage induced by widespread use of conjugate Hib vaccines, which may have contributed to the decline of Hib disease in United States children.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8346003     DOI: 10.1097/00006454-199307000-00009

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  29 in total

1.  Toward elimination of Haemophilus influenzae type B carriage and disease among high-risk American Indian children.

Authors:  E V Millar; K L O'Brien; O S Levine; S Kvamme; R Reid; M Santosham
Journal:  Am J Public Health       Date:  2000-10       Impact factor: 9.308

Review 2.  Limiting the spread of resistant pneumococci: biological and epidemiologic evidence for the effectiveness of alternative interventions.

Authors:  S J Schrag; B Beall; S F Dowell
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

Review 3.  Mucosal immunology of vaccines against pathogenic nasopharyngeal bacteria.

Authors:  Q Zhang; A Finn
Journal:  J Clin Pathol       Date:  2004-10       Impact factor: 3.411

4.  Haemophilus influenzae type b carriage among young children in metropolitan Atlanta in the context of vaccine shortage and booster dose deferral.

Authors:  Jennifer Dolan Thomas; Michael L Jackson; Dolly Sharma; Raydel Mair; Michelle C Bach; Dana Castillo; O Grace Ejigiri; Sarah Satola; Amanda C Cohn; Robert Jerris; Shabnam Jain; Monica M Farley; Leonard W Mayer; Nancy E Messonnier
Journal:  Clin Vaccine Immunol       Date:  2011-10-19

5.  Immunologic response to Haemophilus influenzae type b (Hib) conjugate vaccine and risk factors for carriage among Hib carriers and noncarriers in Southwestern Alaska.

Authors:  Henry C Baggett; Thomas W Hennessy; Lisa Bulkow; Sandra Romero-Steiner; Debra Hurlburt; Patricia Holder; Alan J Parkinson; Rosalyn J Singleton; Orin Levine; George M Carlone; Jay C Butler
Journal:  Clin Vaccine Immunol       Date:  2006-06

6.  Understanding the impact of Hib conjugate vaccine on transmission, immunity and disease in the United Kingdom.

Authors:  J McVernon; M E Ramsay; A R McLean
Journal:  Epidemiol Infect       Date:  2007-08-03       Impact factor: 2.451

7.  Haemophilus influenzae: then and now.

Authors:  J Z Jordens; M P Slack
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-11       Impact factor: 3.267

8.  Subclass distribution of IgA antibodies in saliva and serum after immunization with Haemophilus influenzae type b conjugate vaccines.

Authors:  M Kauppi-Korkeila; L Saarinen; J Eskola; H Käyhty
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

9.  Detection of Haemophilus influenzae type b by real-time PCR.

Authors:  Adrian Marty; Oliver Greiner; Philip J R Day; Sibylle Gunziger; Kathrin Mühlemann; David Nadal
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

10.  Haemophilus influenzae invasive disease in the United States, 1994-1995: near disappearance of a vaccine-preventable childhood disease.

Authors:  K M Bisgard; A Kao; J Leake; P M Strebel; B A Perkins; M Wharton
Journal:  Emerg Infect Dis       Date:  1998 Apr-Jun       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.